Literature DB >> 2506441

Substitution of lysine for arginine at position 42 of human transforming growth factor-alpha eliminates biological activity without changing internal disulfide bonds.

D Defeo-Jones1, J Y Tai, G A Vuocolo, R J Wegrzyn, T L Schofield, M W Riemen, A Oliff.   

Abstract

Transforming growth factor-alpha (TGF-alpha) is a growth-promoting protein that binds to the epidermal growth factor (EGF) receptor. To identify critical residues that govern TGF-alpha-EGF receptor binding, we prepared site-specific substitution mutants of TGF-alpha. Mutant proteins were tested in receptor-binding and mitogenesis assays. Semiconservative substitutions at positions 4, 12, 18, and 45 decreased biological activity 2.1- to 14-fold. The conservative substitution of lysine for arginine at position 42 completely eliminated biological activity. Amino acid composition analysis of proteolytic fragments from TGF-alpha and the Lys-42 mutant indicated that these proteins contained the same disulfide bonds. These studies suggest that arginine 42 may be a contact point for TGF-alpha-EGF receptor interaction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506441      PMCID: PMC362477          DOI: 10.1128/mcb.9.9.4083-4086.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  27 in total

1.  Growth factors from murine sarcoma virus-transformed cells.

Authors:  J E de Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

2.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

3.  A synthetic fragment of rat transforming growth factor alpha with receptor binding and antigenic properties.

Authors:  J J Nestor; S R Newman; B DeLustro; G J Todaro; A B Schreiber
Journal:  Biochem Biophys Res Commun       Date:  1985-05-31       Impact factor: 3.575

4.  Redesigning enzyme structure by site-directed mutagenesis: tyrosyl tRNA synthetase and ATP binding.

Authors:  G Winter; A R Fersht; A J Wilkinson; M Zoller; M Smith
Journal:  Nature       Date:  1982-10-21       Impact factor: 49.962

5.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

6.  Transforming growth factor and epidermal growth factor stimulate the phosphorylation of a synthetic, tyrosine-containing peptide in a similar manner.

Authors:  L J Pike; H Marquardt; G J Todaro; B Gallis; J E Casnellie; P Bornstein; E G Krebs
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

7.  Stimulation of bone resorption in vitro by synthetic transforming growth factor-alpha.

Authors:  K J Ibbotson; D R Twardzik; S M D'Souza; W R Hargreaves; G J Todaro; G R Mundy
Journal:  Science       Date:  1985-05-24       Impact factor: 47.728

8.  Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors.

Authors:  M A Anzano; A B Roberts; J M Smith; M B Sporn; J E De Larco
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles.

Authors:  S Cohen; H Ushiro; C Stoscheck; M Chinkers
Journal:  J Biol Chem       Date:  1982-02-10       Impact factor: 5.157

10.  Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells.

Authors:  J Massagué
Journal:  J Biol Chem       Date:  1983-11-25       Impact factor: 5.157

View more
  8 in total

1.  Structure-function analysis of human transforming growth factor-alpha by site-directed mutagenesis.

Authors:  J A Feild; R H Reid; D J Rieman; T P Kline; G Sathe; R G Greig; M A Anzano
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

2.  Polymorphisms and haplotypes of acid mammalian chitinase are associated with bronchial asthma.

Authors:  Sibylle Bierbaum; Renate Nickel; Anja Koch; Susanne Lau; Klaus A Deichmann; Ulrich Wahn; Andrea Superti-Furga; Andrea Heinzmann
Journal:  Am J Respir Crit Care Med       Date:  2005-09-22       Impact factor: 21.405

3.  Role of the 6-20 disulfide bridge in the structure and activity of epidermal growth factor.

Authors:  K J Barnham; A M Torres; D Alewood; P F Alewood; T Domagala; E C Nice; R S Norton
Journal:  Protein Sci       Date:  1998-08       Impact factor: 6.725

4.  Epiregulin Recognition Mechanisms by Anti-epiregulin Antibody 9E5: STRUCTURAL, FUNCTIONAL, AND MOLECULAR DYNAMICS SIMULATION ANALYSES.

Authors:  Yuji Kado; Eiichi Mizohata; Satoru Nagatoishi; Mariko Iijima; Keiko Shinoda; Takamitsu Miyafusa; Taisuke Nakayama; Takuma Yoshizumi; Akira Sugiyama; Takeshi Kawamura; Young-Hun Lee; Hiroyoshi Matsumura; Hirofumi Doi; Hideaki Fujitani; Tatsuhiko Kodama; Yoshikazu Shibasaki; Kouhei Tsumoto; Tsuyoshi Inoue
Journal:  J Biol Chem       Date:  2015-12-01       Impact factor: 5.157

5.  Preparation and characterization of mono-PEGylated epidermal growth factor: evaluation of in vitro biologic activity.

Authors:  Haeshin Lee; Tae Gwan Park
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

6.  The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity.

Authors:  G D Plowman; J M Green; V L McDonald; M G Neubauer; C M Disteche; G J Todaro; M Shoyab
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

7.  Comparison of the antisecretory and antiulcer activity of epidermal growth factor, urogastrone and transforming growth factor alpha and its derivative in rodents in vivo.

Authors:  S M A Bastaki; S I Chandranath; J Singh
Journal:  Mol Cell Biochem       Date:  2002-07       Impact factor: 3.396

8.  Clinical, genetic, and pathological features of male pseudohermaphroditism in dog.

Authors:  Enrico Bigliardi; Pietro Parma; Paolo Peressotti; Lisa De Lorenzi; Peter Wohlsein; Benedetta Passeri; Stefano Jottini; Anna Maria Cantoni
Journal:  Reprod Biol Endocrinol       Date:  2011-01-21       Impact factor: 5.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.